Vaspin – a link of obesity and psoriasis?
暂无分享,去创建一个
M. Blüher | A. Beck‐Sickinger | A. Saalbach | K. Rall | U. Anderegg | J. Simon | Jenny Tremel | K. Vester | Matthias Blüher | Annette G. Beck-Sickinger | Katharina Vester | Kathrin Rall | Jan C. Simon
[1] M. Okada,et al. Vaspin prevents TNF-α-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-κB and PKCθ activation in cultured rat vascular smooth muscle cells. , 2011, Pharmacological research.
[2] M. Fasshauer,et al. Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects , 2011, Diabetologia.
[3] W. Boehncke,et al. The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity , 2011, Experimental dermatology.
[4] D. Gladman,et al. Cardiovascular Comorbidities in Psoriasis and Psoriatic Arthritis: Pathogenesis, Consequences for Patient Management, and Future Research Agenda: A Report from the GRAPPA 2009 Annual Meeting , 2011, The Journal of Rheumatology.
[5] A. Gottlieb,et al. Comorbidities in patients with psoriasis. , 2009, The American journal of medicine.
[6] F. Cordido,et al. Vaspin and amylin are expressed in human and rat placenta and regulated by nutritional status. , 2009, Histology and histopathology.
[7] T. Kanda,et al. A Novel Adipocytokine, Visceral Adipose Tissue-derived Serine Protease Inhibitor (Vaspin), and Obesity , 2008, The Journal of international medical research.
[8] M. Fasshauer,et al. Serum Vaspin Concentrations in Human Obesity and Type 2 Diabetes , 2008, Diabetes.
[9] J. Gómez-Reino,et al. Adipokines as emerging mediators of immune response and inflammation , 2007, Nature Clinical Practice Rheumatology.
[10] P. Wincker,et al. Large-scale identification of human genes implicated in epidermal barrier function , 2007, Genome Biology.
[11] D. Zahger,et al. Psoriasis and the metabolic syndrome. , 2007, Acta dermato-venereologica.
[12] M. Weichenthal,et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis , 2006, Archives of Dermatological Research.
[13] M. Fasshauer,et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. , 2006, Biochemical and biophysical research communications.
[14] Eijiro Watanabe,et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.